Clinical Trial: Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia

U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT06931912) titled 'Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia' on Jan. 07.

Brief Summary: There are nearly 300,000 patients with severe or intermediate thalassemia in China. Growth retardation is the most significant health issue for children and adolescents with transfusion-dependent thalassemia (TDT), placing a substantial economic burden on their families and a serious social strain on the labor force. Investigating the growth and development of these children and adolescents, and establishing targeted intervention plans, holds significant social value for public health practice.

1. T...